News

Caduet Combination Tablets are oral combination drug of Norbasc Tablets and Lipitor Tablets. Under the agreement, Pfizer is responsible to seek marketing approval for the product in Japan,

The company said the decision is still subject to the approval of board members. Most recently, Kress worked as the vice president and general manager for Gilead France

AMT has developed Glybera for the treatment of patients who are suffering from genetic disorder lipoprotein lipase deficiency (LPLD). The re-examination of the dossier is expected to be

SAFC provides raw materials and process development services to establish the CHOZN series of cell lines to build therapeutic protein and monoclonal antibody manufacturing platform. SAFC Cell Sciences

Currently, he is serving as the executive VP of Business Development of the company and joined the subsidiary of Kyowa Hakko Kirin (KHK), ProStrakan in 1997. Stratford said

Palonosetron (palonosetron hydrochloride) is a second generation 5-HT3 Receptor Antagonist, developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer. Longo said in their

As per the agreement, both the parties have decided to work together for identifying ventures and technologies from academia and early stage projects in Texas for strengthening R&D

Drug transporters are a family of proteins that move substances across cellular membranes, both into and out of the cells. Cyprotex is a contract research organisation specialising in

Developed by ProMetic’s subsidiary ProMetic Biosciences, Mimetic Ligand affinity adsorbent is expected to be supplied in the third and fourth quarters of 2011. Further, the supply agreement allows